of The University of California Regents

of The University of California Regents is a declared insider at 2 companies (board member); the most frequent names are Blue Owl Capital Corp and Constellation Pharmaceuticals Inc. In total, 81 filings cover trades dated from 27 December 2016 to 16 June 2021.

The open-market side counts 7 purchases for €255.8M alongside 67 sales for €92.2M. Taken together, the purchases exceed the sales by €163.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2021 alone, the filings show no purchases and 40 sales.

A typical purchase (the median) is worth €35.0M.

On 17 June 2021 came the latest disclosure, an open-market sale for €1.5M in Blue Owl Capital Corp. The latest purchase dates back some time: it was published 3,014 days ago, on 8 August 2018. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.